Clinical Implications of APC Mutation Driven Dysregulation of Intestinal Regulators of Proliferation and Differentiation: A Systematic Review Identifying Factors Governing Onset of Colorectal Carcinoma

Objective: With a focus on clinical implications toward early detection, this study investigates how APC loss disrupts intestinal stem cell regulatory networks by simultaneously enhancing proliferation signaling programs and suppressing key differentiation enforcers, thereby driving colorectal carcinoma development. Background: Colorectal cancer commonly begins with APC mutation, yet the earliest biological events driving initiation remain unclear. Intestinal homeostasis depends on a tightly regulated balance between stem cell proliferation and differentiation. Emerging evidence shows APC loss not only activates proliferative Wnt signaling but also suppresses differentiation programs, collapsing epithelial identity. Investigating how APC disrupts intestinal stem cell regulatory networks is crucial to define the true cell of origin, identify early drivers, and enable earlier detection and prevention of CRC. Methods: Databases, including PubMed, MEDLINE, Scopus, and Web of Science were searched through March 2026, to investigate how APC loss simultaneously amplifies proliferation programs (Wnt/beta catenin, Ascl2, Sox9, c Myc, YAP, EGFR) and actively suppresses differentiation enforcers (Klf4, Atoh1, Gfi1, Neurog3, Hes6, BMP/SMAD, Shh, Notch inhibition), involved in intestinal stem cell regulatory networks, to drive colorectal carcinoma development. Studies meeting the criteria outlined in the methods section were systematically reviewed to address the research question. This study adheres to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta Analyses) guidelines. Results: APC mutation irreversibly damages the intestinal proliferation and differentiation balance by simultaneously amplifying proliferation programs and suppressing differentiation regulators. Constitutive Wnt/beta catenin activation upregulates Lgr5, Ascl2, Sox9, c Myc, YAP, and EGFR, while actively repressing Klf4, Atoh1, Gfi1, Neurog3, Hes6, BMP/SMAD, Shh, and Notch inhibitory signals. This dual imbalance traps progenitor cells in a hyperproliferative, differentiation incompetent state, driving crypt hyperplasia, clonal expansion, and early colorectal cancer initiation before overt genetic complexity emerges. Conclusion: These findings suggest colorectal cancer initiation arises from a developmental state change rather than a single mutated cell. APC mutation dysregulates the intestinal regulators, enforcing persistent Wnt driven proliferation while silencing differentiation regulators such as Klf4, Atoh1, Gfi1, BMP/SMAD, and Shh. This traps stem progenitor cells in a plastic, undifferentiated state incapable of fate resolution. The earliest irreversible event is loss of differentiation competence, creating clonally expanding, mutation prone crypts. CRC thus begins as a disease of disrupted epithelial identity, not merely accumulated genetic damage during early tumorigenesis stages.